SIGA Technologies Inc (SIGA)
8.72
+0.08
(+0.93%)
USD |
NASDAQ |
Apr 26, 14:59
SIGA Technologies Enterprise Value: 464.09M for April 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 464.09M |
| April 24, 2024 | 465.51M |
| April 23, 2024 | 472.62M |
| April 22, 2024 | 443.47M |
| April 19, 2024 | 442.76M |
| April 18, 2024 | 434.94M |
| April 17, 2024 | 454.84M |
| April 16, 2024 | 484.70M |
| April 15, 2024 | 481.15M |
| April 12, 2024 | 476.17M |
| April 11, 2024 | 504.61M |
| April 10, 2024 | 506.03M |
| April 09, 2024 | 508.87M |
| April 08, 2024 | 489.68M |
| April 05, 2024 | 495.37M |
| April 04, 2024 | 487.55M |
| April 03, 2024 | 554.37M |
| April 02, 2024 | 535.89M |
| April 01, 2024 | 474.75M |
| March 28, 2024 | 458.40M |
| March 27, 2024 | 454.13M |
| March 26, 2024 | 441.34M |
| March 25, 2024 | 443.47M |
| March 22, 2024 | 472.62M |
| March 21, 2024 | 483.99M |
| Date | Value |
|---|---|
| March 20, 2024 | 473.33M |
| March 19, 2024 | 442.76M |
| March 18, 2024 | 415.03M |
| March 15, 2024 | 370.96M |
| March 14, 2024 | 341.10M |
| March 13, 2024 | 308.40M |
| March 12, 2024 | 228.06M |
| March 11, 2024 | 197.49M |
| March 08, 2024 | 195.36M |
| March 07, 2024 | 204.60M |
| March 06, 2024 | 206.73M |
| March 05, 2024 | 202.47M |
| March 04, 2024 | 211.71M |
| March 01, 2024 | 220.24M |
| February 29, 2024 | 220.24M |
| February 28, 2024 | 228.77M |
| February 27, 2024 | 231.62M |
| February 26, 2024 | 220.95M |
| February 23, 2024 | 228.06M |
| February 22, 2024 | 215.26M |
| February 21, 2024 | 218.82M |
| February 20, 2024 | 210.29M |
| February 16, 2024 | 215.98M |
| February 15, 2024 | 215.98M |
| February 14, 2024 | 206.02M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
170.48M
Minimum
Feb 05 2024
1.795B
Maximum
Aug 15 2022
434.48M
Average
410.04M
Median
Jun 19 2019
Enterprise Value Benchmarks
| Geron Corp | 1.692B |
| SELLAS Life Sciences Group Inc | 83.00M |
| Heron Therapeutics Inc | 476.68M |
| FibroGen Inc | -20.94M |
| Clearside Biomedical Inc | 65.23M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 72.26M |
| Revenue (Quarterly) | 116.48M |
| Total Expenses (Quarterly) | 24.80M |
| EPS Diluted (Quarterly) | 1.01 |
| Gross Profit Margin (Quarterly) | 85.04% |
| Profit Margin (Quarterly) | 62.03% |
| Earnings Yield | 10.89% |
| Operating Earnings Yield | 13.38% |
| Normalized Earnings Yield | 10.89 |